HuGE Literature Finder
Records
1
-
30
| Warfarin dose requirement in patients having severe thrombosis or thrombophilia. British journal of clinical pharmacology 2019 Apr . Helin Tuukka A, Joutsi-Korhonen Lotta, Asmundela Heidi, Niemi Mikko, Orpana Arto, Lassila Riit |
| Prosthetic valve thrombosis - association of genetic polymorphisms of VKORC1, CYP2C9 and CYP4F2 genes. Medicine 2019 Feb 98 (6): e14365. Sr Kalpana, G Bharath, Jain Simran, Moorthy Nagaraja, Manjunath Satvic C, Christopher Ri |
| The Influence of CYP2C9 and VKORC1 Gene Polymorphisms on the Response to Warfarin in Egyptians. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2018 Apr 34 (2): 328-336. Bedewy Ahmed M L, Showeta Salah, Mostafa Mostafa Hasan, Kandil Lamia Sae |
| Association Between the Lower Extremity Deep Venous Thrombosis, the Warfarin Maintenance Dose, and CYP2C9*3, CYP2D6*10, and CYP3A5*3 Genetic Polymorphisms: A Case-Control Study. Genetic testing and molecular biomarkers 2017 Sep . Ju Shang, Gao Yu, Cao Xin, Zhang Xiao-Fu, Yan Cheng-Cheng, Liu Feng-To |
| Long-term outcomes of elderly patients with CYP2C9 and VKORC1 variants treated with vitamin K antagonists. Journal of thrombosis and haemostasis : JTH 2017 Aug . Nagler M, Angelillo-Scherrer A, Méan M, Limacher A, Abbal C, Righini M, Beer J H, Osterwalder J, Frauchiger B, Aschwanden M, Matter C M, Kucher N, Cornuz J, Banyai M, Husmann M, Staub D, Mazzolai L, Hugli O, Rodondi N, Aujesky |
| Integrated analysis of genetic variation and gene expression reveals novel variant for increased warfarin dose requirement in African Americans. Journal of thrombosis and haemostasis : JTH 2017 Jan . Hernandez Wenndy, Gamazon Eric R, Aquino-Michaels Keston, Smithberger Erin, O'Brien Travis J, Harralson Arthur F, Tuck Matthew, Barbour April, Cavallari Larisa H, Perera Minoli |
| VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients. Medicine 2016 Dec 95 (52): e5451. Misasi Silvia, Martini Giuliana, Paoletti Oriana, Calza Stefano, Scovoli Giovanni, Marengoni Alessandra, Testa Sophie, Caimi Luigi, Marchina Eleono |
| Identification of novel variants associated with warfarin stable dosage by use of a two-stage extreme phenotype strategy. Journal of thrombosis and haemostasis : JTH 2016 Oct . Luo Zhiying, Li Xi, Zhu Mingfeng, Tang Jie, Li Zhi, Zhou Xinming, Song Guobao, Liu Zhaoqian, Zhou Honghao, Zhang W |
| [FREQUENCY OF POLYMORPHISM OF VKORC1 AND CYP2C9 GENES IN TWO REGIONS OF GEORGIA]. Georgian medical news 2016 Jan (250): 46-51. Jokhadze T, Kakauridze N, Buadze T, Gaiozishvili M, Lezhava |
| Effects of genetic factors to stent thrombosis due to clopidogrel resistance after coronary stent placement. Cellular and molecular biology (Noisy-le-Grand, France) 2016 62 (1): 51-5. Kirac D, Erdem A, Avcilar T, Yesilcimen K, Guney A I, Emre A, Yazici S, Terzi S, Kaspar E C, Cetin S E, Isbir |
| High prevalence of VKORC1*3 (G9041A) genetic polymorphism in north Indians: A study on patients with cardiac disorders on acenocoumarol. Drug discoveries & therapeutics 2016 9 (6): 404-10. Sehgal Tushar, Hira Jasbir Kaur, Ahluwalia Jasmina, Das Reena, Vijayvergiya Rajesh, Rana Sandip Singh, Varma Neel |
| Pharmacogenomic Testing and Warfarin Management. Oncology nursing forum 2015 Sep 42 (5): 563-5. Maluso Andr |
| Influence of CYP2C9 polymorphism on the fall in International Normalized Ratio in patients interrupting warfarin therapy before elective surgery. Journal of thrombosis and haemostasis : JTH 2015 Aug 13 (8): 1436-40. Abohelaika S, Wynne H, Avery P, Kamali |
| The Influence of VKORC1 Polymorphisms on Warfarin Doses in Thai Patients with Deep Vein Thrombosis. Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2015 Jun 98 (6): 549-54. Sermsathanasawadi Nuttawut, Sritongsathian Chukij, Pongrattanaman Nunthapol, Praditsuktavorn Banjerd, Hongku Kiattisak, Wongwanit Chumpol, Ruangsetakit Chanean, Chinsakchai Khamin, Mutirangura Pramook, Poungvarin Narav |
| Polymorphisms of CYP2C9, VKORC1, MDR1, APOE and UGT1A1 genes and the therapeutic warfarin dose in Brazilian patients with thrombosis: a prospective cohort study. Molecular diagnosis & therapy 2014 Dec 18 (6): 675-83. de Oliveira Almeida Vanessa Cristina, Ribeiro Daniel Dias, Gomes Karina Braga, Godard Ana Lúcia Brunial |
| Effects on bleeding complications of pharmacogenetic testing for initial dosing of vitamin K antagonists: a systematic review and meta-analysis. Journal of thrombosis and haemostasis : JTH 2014 Sep 12 (9): 1480-7. Franchini M, Mengoli C, Cruciani M, Bonfanti C, Mannucci P |
| VKORC1 and CYP2C9 genotypes in Egyptian patients with warfarin resistance. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2014 Jun . Azzam Hanan, Elwakeel Hossam, Awad Ibrahim, El-Farahaty Reham, El-Gilany Abdel-Hady, El-Sharawy Sola |
| Influence of CYP2C9 polymorphism and phenytoin co-administration on acenocoumarol dose in patients with cerebral venous thrombosis. Thrombosis research 2014 May 133 (5): 729-35. De Tanima, Christopher Rita, Nagaraja Dindag |
| High resolution melting method to detect single nucleotide polymorphism of VKORC1 and CYP2C9. International journal of clinical and experimental pathology 2014 7 (5): 2558-64. Chen Chunxia, Li Siyue, Lu Xiaojun, Tan Bin, Huang Chunyan, Qin |
| An acenocoumarol dose algorithm based on a South-Eastern European population. European journal of clinical pharmacology 2013 Nov 69 (11): 1901-7. Pop Tudor Radu, Vesa ?tefan Cristian, Trifa Adrian Pavel, Cri?an Sorin, Buzoianu Anca Da |
| Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease. JACC. Cardiovascular interventions 2013 Nov 6 (11): 11. Viviani Anselmi C, Briguori C, Roncarati R, Papa L, Visconti G, Focaccio A, De Micco F, Latronico MV, Pagnotta P, Condorelli G |
| The prevalence of VKORC1 1639 G>A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population. Molecular biology reports 2012 Oct . Silan C, Dogan OT, Silan F, Kukulguven FM, Asgun HF, Ozdemir S, Uludag A, Atik S, Gungor B, Akdur S, Aksulu HE, Ozdemir O |
| Warfarin pharmacogenetics: development of a dosing algorithm for Omani patients. Journal of human genetics 2012 Oct 57 (10): 665-9. Pathare Anil, Al Khabori Murtadha, Alkindi Salam, Al Zadjali Shoaib, Misquith Rhea, Khan Hammad, Lapoumeroulie Claudine, Paldi Andras, Krishnamoorthy Rajagop |
| An evaluation of gene-gene interaction between the CYP2C9 and VKORC1 genotypes affecting the anticoagulant effect of phenprocoumon and acenocoumarol. Journal of thrombosis and haemostasis : JTH 2012 May 10 (5): 767-72. van Schie R M F, Babajeff A M V, Schalekamp T, Wessels J A M, le Cessie S, de Boer A, van der Meer F J M, van Meegen E, Verhoef T I, Rosendaal F R, Maitland-van der Zee A H, |
| Long-term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol users. Journal of thrombosis and haemostasis : JTH 2012 Apr 10 (4): 606-14. Verhoef T I, Redekop W K, Buikema M M, Schalekamp T, Van Der Meer F J M, Le Cessie S, Wessels J A M, Van Schie R M F, De Boer A, Teichert M, Visser L E, Maitland-Van Der Zee A H, |
| Increased warfarin consumption and residual fibrin turnover in thrombotic patients with primary antiphospholipid syndrome. Thrombosis research 2011 Jun 127 (6): 595-9. Ames Paul R J, Margaglione Maurizio, Ciampa Antonio, Colaizzo Donatella, Ferrara Felicetto, Iannaccone Luigi, Vincenzobrancacci |
| CYP2C9 polymorphism studies in the Saudi population. Saudi medical journal 2011 Apr 32 (4): 347-52. Saour Jalal N, Shereen Atia W, Saour Basil J, Mammo Layla |
| Predicting the warfarin maintenance dose in elderly inpatients at treatment initiation: accuracy of dosing algorithms incorporating or not VKORC1/CYP2C9 genotypes. Journal of thrombosis and haemostasis : JTH 2011 Apr 9 (4): 711-8. Moreau C, Pautas E, Gouin-Thibault I, Golmard J-L, Mahé I, Mulot C, Loriot M-A, Siguret |
| Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment. Journal of thrombosis and haemostasis : JTH 2011 Jan 9 (1): 109-18. Watzka M, Geisen C, Bevans C G, Sittinger K, Spohn G, Rost S, Seifried E, Müller C R, Oldenburg |
| [Polymorphisms of genes CYP2C9 and VKORC1 in patients with venous thromboembolic complications in Moscow population: effects on stability of anticoagulant therapy and frequency of hemorrhage]. Terapevticheski? arkhiv 2011 83 (6): 59-65. Vorob'eva N M, Panchenko E P, Dobrovol'ski? A B, Titaeva E V, Khasanova Z B, Konovalova N V, Postnov A Iu, Kirienko A |
- Page last reviewed:Oct 1, 2021
- Page last updated:May 26, 2022
- Content source: